Literature DB >> 1431909

Specific irreversible monoamine oxidase B inhibitors stimulate gene expression of aromatic L-amino acid decarboxylase in PC12 cells.

X M Li1, A V Juorio, I A Paterson, M Y Zhu, A A Boulton.   

Abstract

The effect of some selective monoamine oxidase (MAO) inhibitors on aromatic L-amino acid decarboxylase (AADC) gene expression in PC12 cells has been examined. Irreversible MAO B inhibitors [(-)-deprenyl, pargyline, and MDL 72,974A] stimulated AADC gene expression, whereas a selective irreversible MAO A inhibitor (clorgyline) and a reversible MAO B inhibitor (Ro 19-6327) had no effect. Because there is no apparent MAO B activity in PC12 cells, it is postulated that there is a novel site of action for these MAO B inhibitors and that the pharmacological profile of this site matches that of neuroprotective MAO B inhibitors. Finally, it is suggested that the stimulation of AADC gene expression may be relevant to the antiparkinsonian effects of MAO B inhibitors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431909     DOI: 10.1111/j.1471-4159.1992.tb10127.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

Review 1.  Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme.

Authors:  M D Berry; A V Juorio; X M Li; A A Boulton
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

2.  New mechanisms of action of irreversible monoamine oxidase type B inhibitors.

Authors:  X M Li; A V Juorio; I A Paterson; A A Boulton
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

3.  Elevated dopa decarboxylase activity in living brain of patients with psychosis.

Authors:  J Reith; C Benkelfat; A Sherwin; Y Yasuhara; H Kuwabara; F Andermann; S Bachneff; P Cumming; M Diksic; S E Dyve; P Etienne; A C Evans; S Lal; M Shevell; G Savard; D F Wong; G Chouinard; A Gjedde
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

4.  Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.

Authors:  I Lamensdorf; S Porat; R Simantov; J P Finberg
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl.

Authors:  J S Wadia; R M Chalmers-Redman; W J Ju; G W Carlile; J L Phillips; A D Fraser; W G Tatton
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

6.  NSD-1015 alters the gene expression of aromatic L-amino acid decarboxylase in rat PC12 pheochromocytoma cells.

Authors:  X M Li; A V Juorio; A A Boulton
Journal:  Neurochem Res       Date:  1993-08       Impact factor: 3.996

7.  Induction of aromatic L-amino acid decarboxylase mRNA by interleukin-1 beta and prostaglandin E2 in PC12 cells.

Authors:  X M Li; A V Juorio; A A Boulton
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

8.  Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.

Authors:  Junichi Kitanaka; Nobue Kitanaka; Motohiko Takemura
Journal:  Drug Target Insights       Date:  2006-11-09

9.  Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity.

Authors:  C B Seymour; C Mothersill; R Mooney; M Moriarty; K F Tipton
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

10.  Dengue Virus Replication Is Associated with Catecholamine Biosynthesis and Metabolism in Hepatocytes.

Authors:  George Mpekoulis; Vassilina Tsopela; Anna Chalari; Katerina I Kalliampakou; Georgios Panos; Efseveia Frakolaki; Raphaela S Milona; Diamantis C Sideris; Dido Vassilacopoulou; Niki Vassilaki
Journal:  Viruses       Date:  2022-03-09       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.